L. Sandalic

发表

Randomized, phase IIb study of low-dose cytarabine and lintuzumab versus low-dose cytarabine and placebo in older adults with untreated acute myeloid leukemia

B. Wood, J. Lancet, M. Sekeres, 2013, Haematologica.

Phase III Trial Comparing Paclitaxel Poliglumex (CT-2103, PPX) in Combination with Carboplatin Versus Standard Paclitaxel and Carboplatin in the Treatment of PS 2 Patients with Chemotherapy-Naïve Advanced Non-small Cell Lung Cancer

M. Socinski, K. O'Byrne, T. Ciuleanu, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Serum-free estradiol (E2) levels are prognostic in men with chemotherapy-naive advanced non-small cell lung cancer (NSCLC) and performance status (PS) 2

J. Singer, P. Bonomi, F. Oldham, 2007 .

Bayesian dose escalation in oncology with sharing of information between patient populations.

S. Berry, K. Broglio, Tina M. Albertson, 2015, Contemporary clinical trials.

M. Socinski, K. O'Byrne, T. Ciuleanu, 2008 .

Lintuzumab and Low-Dose Cytarabine Compared to Placebo and Low-Dose Cytarabine in Patients with Untreated Acute Myeloid Leukemia (AML) 60 Years and Older: Results of a Randomized, Double-Blinded Phase 2b Study,

B. Wood, J. Lancet, M. Sekeres, 2011 .

Randomized Phase III Trial Comparing Single-Agent Paclitaxel Poliglumex (CT-2103, PPX) with Single-Agent Gemcitabine or Vinorelbine for the Treatment of PS 2 Patients with Chemotherapy-Naïve Advanced Non-small Cell Lung Cancer

M. Socinski, Y. Hotko, J. Singer, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Interim Analysis of a Phase 1 Study of the Antibody-Drug Conjugate SGN-CD19A in Relapsed or Refractory B-Lineage Acute Leukemia and Highly Aggressive Lymphoma

L. Silverman, D. DeAngelo, U. Borate, 2014 .

Interim Analysis of a Phase 1 Study of the Antibody-Drug Conjugate SGN-CD19A in Relapsed or Refractory B-Lineage Non-Hodgkin Lymphoma

R. Advani, B. Shah, P. Hamlin, 2014 .

A First-In-Human Phase 1 Study Of The Antibody-Drug Conjugate SGN-CD19A In Relapsed Or Refractory B-Lineage Acute Leukemia and Highly Aggressive Lymphoma

L. Silverman, D. DeAngelo, U. Borate, 2013 .

Evaluation of Nicotine Pharmacokinetics and Subjective Effects following Use of a Novel Nicotine Delivery System

F. Lüdicke, M. Laugesen, C. Wynne, 2017, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

Phase II Trial of Dabrafenib Plus Trametinib in Relapsed/Refractory BRAF V600–Mutant Pediatric High-Grade Glioma

O. Witt, A. Kieloch, D. Hargrave, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Interim analysis of a phase 1, open-label, dose-escalation study of SGN-CD19A in patients with relapsed or refractory B-lineage non-Hodgkin lymphoma (NHL).

R. Advani, B. Shah, A. Forero-Torres, 2014 .

561P Phase Ib study of ribociclib (R) + trametinib (T) in patients (pts) with metastatic/advanced solid tumours

J. Desai, G. Shapiro, A. Boran, 2020 .